Mon, Jul 28, 2014, 8:40 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Sangamo Biosciences Inc. Message Board

  • Rob_Cos Rob_Cos Sep 25, 2007 5:14 PM Flag

    CF"Game changing. Not linear-mkt disruptive. SIGNIFANTLY undervalued. $17 tgt!!

    Cantor Fitz-"SGMO Scores - Dow Agro/Mons deal Relies on ZFP. Dow/SGMO tech ahead of schedule and more powerful than anticipated. Game changing. New Industry Std. Not Linear but "Market Disruptive". SIGNIFICANTLY UNDERVALUED. $17 target. BUY"

    Full report:

    http://www1.investorvillage.com/smbd.asp?mb=1933&mn=871&pt=msg&mid=3079593


    Cantor Fitzgerlald
    SEPTEMBER 14, 2007

    Equity Research

    Rating: BUY - Target Price: $17.00

    Sangamo Scores - Dow AgroSciences/Monsanto Collaboration Relies on ZFP Tech

    o As we highlighted in our note last week (Dow AgroSciences Signals Sangamo Alliance Positive Progress- BUY, September 5, 2007), regarding the Sangamo/Dow AgroSciences alliance, the positive progress we anticipated was confirmed today in the conference call following the Dow AgroSciences/Monsanto collaboration announced before the market open this morning.

    o During the call, Dow confirmed that progress involving its collaboration around Sangamo's ZFP technology platform for gene regulation and modification of plants and plant cell cultures � the actionable step toward creating new products after the genes are identified and validated - IS AHEAD OF SCHEDULE AND MORE POWERFUL THAN ANTICIPATED.

    o Both Monsanto and Dow characterize their collaboration, which brings together their respective biotechnology platforms to create the first eight-gene stack offering, branded SmartStax, AS THE NEW INDUSTRY-STANDARD.

    o We think the transformative nature of the integrated DowAgro technology platform � highly reliant on Sangamo's ZFP technology, in our view � positions the company to achieve sustainable top-line and bottom-line growth involving the world's largest and most lucrative markets � food/agro, bioenergy and bioindustrials � that will flow through to Sangamo.

    o We remind investors that technology-driven growth is not linear � it is market-disruptive and we consider the integration of Sangamo's ZFP technology into Dow's platform game-changing. We think SGMO is SIGNIFICANTLY UNDERVALUED and reiterate our BUY rating.

 
SGMO
12.00-0.32(-2.60%)Jul 28 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.